{
  "content": [
    {
      "type": "text",
      "text": "# Ann King Cashion\n\nAnn King Cashion is a woman that is part of the American Academy of Nursing, she is one of the highest honors in the nursing profession. This is important! She represents women who want a higher education in STEM/ Nursing field.\nAnn King Cashion is an American nurse scientist specialized in genetic markers that predict clinical outcomes. She is a professor emerita in the department of health promotion/disease prevention at the University of Tennessee Health Science Center. Cashion was the acting director of the National Institute of Nursing Research from 2018 to 2019.\nLife\nCashion completed a B.S.N. in Nursing at the University of North Carolina at Chapel Hill in 1978. She earned a MNSc in Nursing/Adult at the University of Arkansas for Medical Sciences. Cashion practiced as a critical care nurse and clinical nurse specialist for nearly two decades in Little Rock, Arkansas. She completed a Ph.D. in Nursing at the University of Tennessee Health Science Center in 1998. Her dissertation was titled Measurement of Autonomic Function in Renal Disease and Diabetes. Kay F. Engelhardt was her doctoral advisor. In 2000, she completed postdoctoral research in molecular genetics at the National Institute of Nursing Research and Georgetown University.\nIn 2000, Cashion joined the faculty of the College of Nursing at the University of Tennessee Health Science Center (UTHSC). From 2008 to 2013, she was a professor in the college of nursing. Cashion chaired the department of acute and chronic care from 2005 to 2012. In 2006, she was elected a fellow of the American Academy of Nursing. During her tenure there, Cashion researched social, environmental and genetic markers to predict patient outcomes and guide therapies in solid organ transplant recipients. She researched the factors leading to post-transplant weight gain. Her expertise is in genetic markers that predict clinical outcomes, in particular the genetic/genomic and environmental components associated with outcomes of organ transplantation.\nCashion combined genomic technology (microarrays) and behavioral questionnaires to investigate the gene-environment interactions leading to obesity in recipients of kidney transplantations during the first year after transplant. She expanded her work as the lead investigator of NINRâ€™s Genomic and Clinical Biomarkers Lab, where she uses the NIH-Symptom Science Model to identify biomarkers to predict \"at-risk\" populations and guide therapeutic management for multiple health outcomes. Cashion served as president of the International Society of Nurses in Genetics.\nCashion joined the National Institute of Nursing Research (NINR) in 2011 as a senior advisor to then-NINR director Patricia A. Grady. She served as acting scientific director before being appointed permanently in November 2013. She was named NINR acting deputy director in January 2018. Cashion was the acting NINR director from September 2018 until September 30, 2019. Lawrence A. Tabak succeeded Cashion as the acting NINR director.\nOn July 1, 2020, Cashion rejoined the UTHSC as a professor in the college of nursing. As of 2022, she is a professor emerita in the department of health promotion/disease prevention.\nReferences\n[https://nihrecord.nih.gov/2018/03/09/cashion-named-ninr-acting-deputy-director Cashion Named NINR Acting Deputy Director | NIH Record]"
    }
  ]
}